A new role of protein phosphatase 2A in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells

Cancer Research

Volumn 64, Issue 17, 2004, Pages 5938-5942

  Liao, Yong ^a   Hung, Mien Chie ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; CASPASE 9; E1A PROTEIN; OKADAIC ACID; PACLITAXEL; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN BCL 2; PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL LYSATE; CELL STRAIN MCF 7; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ASSAY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA SYNTHESIS;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; APOPTOSIS; BREAST NEOPLASMS; CATALYTIC DOMAIN; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 4344686261     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1533     Document Type: Article

References (15)

1. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signaling. Biochem J 2001;353: 417-39.
2. Schonthal AH. Role of serine/threonine protein phosphatase 2A in cancer. Cancer Lett 2001;170:1-13.
3. Simpson L, Parsons R. PTEN: life as a tumor suppressor. Exp Cell Res 2001;264: 29-41.
4. Van Hoof C, Goris J. PP2A fulfills its promises as tumor suppressor: which subunits are important? Cancer Cell 2004;5:105-6.
5. Gotz J, Probst A, Ehler E, Hemmings B, Kues W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Cα. Proc Natl Acad Sci USA 1998;95:12370-5.
6. Liu W, Akhand AA, Takeda K, et al. Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ 2003;10:772-81.
7. Matsuoka Y, Nagahara Y, Ikekita M, Shinomiya T. A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br J Pharmacol 2003;138:1303-12.
8. Choi SH, Lyu SY, Park WB. Mistletoe lectin induces apoptosis and telomerase inhibition in human A253 cancer cells through dephosphorylation of Akt. Arch Pharm Res 2004;27:68-76.
9. Viniegra JG, Losa JH, Sanchez-Arevalo VJ, et al. Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin. Oncogene 2002;21:7131-6.
10. Liao Y, Hung MC. Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis. Mol Cell Biol 2003;23:6836-48.
11. Liao Y, Zou YY, Xia, WY, Hung, MC. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a non-viral mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer. Cancer Gene Ther. In press 2004;11.
12. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev 2002; 16:948-58.
13. Yuan ZQ, Feldman RI, Sussman GE, Coppola D, Nicosia SV, Cheng JQ. AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance. J Biol Chem 2003;278:23432-40.
14. Blagosklonny MV, Fojo T. Molecular effects of paclitaxel: myths and reality (a critical review). Int J Cancer 1999;83:151-6.
15. Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-64.